Triveni Bio

Breaking Efficacy Ceilings

Watertown, United States · Founded 2023 · $272.0M raised

Headquarters
Watertown
Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$272.0M
Last Round
$65.0M Venture RoundJun 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Triveni Bio is a clinical-stage biotech company taking a genetics-informed approach and leveraging advanced antibody engineering to build first-in-class therapeutics for immune and inflammatory diseases. The company combines human genetics insights with novel antibody engineering to address root causes of conditions like atopic dermatitis. It is backed by Atlas Venture and headquartered in the Boston/Cambridge area.

Summary

Triveni Bio is a Biotech company based in Watertown, United States, founded in 2023. It has raised $272.0M in total across 3 rounds, most recently a $65.0M Venture Round in Jun 2026. Investors include Goldman Sachs Alternatives, Atlas Venture and Cormorant Asset Management.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding RoundJun 2026
$65.0M

Sign up to see all 3 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triveni Bio on Indexed.vc
<a href="https://indexed.vc/companies/triveni-bio"><img src="https://indexed.vc/api/badge/company/triveni-bio" alt="Triveni Bio on Indexed.vc" width="260" height="76" /></a>